GlassScriptPhysician profile
Ahmed S Bata
NPI 1184864423
$1,223.01
in general payments reported to CMS, 2019-2025
25 companies · $291 in 2025
The $291 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $122 · 2021: $74.40 · 2022: $147 · 2023: $234 · 2024: $125 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $649.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $200.99 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $185.92 | 2019-2025 | Pangea, Citrefix, Easyfuse |
| Smith+Nephew, INC. | $137.57 | 2020-2025 | Stravix Pl, Stravix |
| Radius Health, INC. | $118.24 | 2019 | |
| Abbvie INC. | $107.32 | 2022-2024 | Dalvance |
| Zimmer Biomet Holdings, INC. | $64.32 | 2019-2021 | |
| Polynovo North America LLC | $40.41 | 2025 | Novosorb Btm |
| Mimedx Group, INC. | $39.73 | 2025 | |
| Paragon 28, INC. | $31.90 | 2025 | Mtp |
| Wright Medical Technology, INC. | $30.62 | 2019 | |
| Fidia Pharma USA INC. | $25.35 | 2025 | Hymovis |
| Cardiovascular Systems INC. | $24.89 | 2022 | |
| Amgen INC. | $23.58 | 2020 | |
| Biomarin Pharmaceutical INC. | $23.37 | 2022 | |
| Medtronic, INC. | $22.37 | 2023 | Mazor X System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $21.05 | 2022 | |
| Boston Scientific Corporation | $16.90 | 2021 | |
| Glaxosmithkline, LLC. | $15.72 | 2024 | Shingrix |
| Arthrosurface Incorporated | $14.73 | 2019 | |
| International Rehabilitative Sciences, INC | $14.30 | 2024 | Rs-4i Plus Sequential Stimulator |
| Vital Orthopedics LLC | $13.77 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $13.54 | 2020 | |
| Organogenesis INC. | $13.38 | 2024 | |
| Trevena, INC. | $11.83 | 2021 | |
| Djo, LLC | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Bata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.